Free provider profile
ARJUN REYES, MD
NPI 1194834424
Individual
Psychiatry & Neurology, Psychiatry
Active registration
Save to rep workspaceNPI registry Registry record
Source: CMS NPPES registry, updated continuously. This record was last updated 2014-06-05.
893 PATRIOT DR STE A, MOORPARK, CA, 93021
805-531-1000
Single practice location
Enumerated 2006-08-30
- — Registration is active in NPPES.
- — Individual clinician record — reachable, but usually not the buyer.
- — Practice phone number is published.
- — Full street address on file for route planning.
- — 1 payer identifiers on file — enrolled with payers.
- — Record last updated 12 years ago.
Medicare Part D prescribing
Source: CMS Medicare Part D Prescribers by Provider, most recent public year.
Part D claims
3,945
Medicare patients
219
Part D drug cost
$253,568
Brand-name share
4.3%
of this prescriber's Part D claims
| Drug | Claims | Medicare cost |
|---|---|---|
| Vraylar (Cariprazine Hcl) | 29 | $45,881 |
| Spravato (Esketamine Hcl) | 12 | $13,538 |
| Divalproex Sodium (Divalproex Sodium) | 122 | $11,612 |
| Vyvanse (Lisdexamfetamine Dimesylate) | 15 | $10,959 |
| Clozapine (Clozapine) | 100 | $8,260 |
| Aripiprazole (Aripiprazole) | 120 | $7,406 |
| Quetiapine Fumarate (Quetiapine Fumarate) | 254 | $6,807 |
| Belsomra (Suvorexant) | 13 | $5,642 |
Want their full drug mix and peer benchmark? Run the free Part D prescriber lookup.
Spravato (esketamine) Medicare billing
Source: CMS Medicare Part B fee-for-service, HCPCS G2082/G2083.
2024114 sessions · 11 patients · $126,245
Full Spravato label-compliance detail — sessions per patient against the FDA label, risk flags and year-over-year trend.
- Registry data comes straight from CMS NPPES, which lists registration, not activity — a listed practice may have moved or closed.
- Part D covers Medicare prescription drug enrollees only. Commercial, Medicaid and cash-pay prescribing is not included, so these figures are a floor on real volume, not the whole picture.
- CMS publishes the Part D file annually, roughly two years behind the prescribing year. Drugs with 10 or fewer claims are suppressed.